INNV Quote, Financials, Valuation and Earnings

AMN Healthcare Services, Inc. has a net margin of 3.25% compared to InnovAge Holding Corp.'s net margin of 4.62%. InnovAge Holding Corp.'s return on equity of -7.99% beat AMN Healthcare Services, Inc.'s return on equity of -38.65%.

InnovAge Holding Corp. has a consensus price target of $5.00, signalling downside risk potential of -2.91%. On the other hand AMN Healthcare Services, Inc. has an analysts' consensus of $20.71 which suggests that it could grow by 25.01%. Given that AMN Healthcare Services, Inc. has higher upside potential than InnovAge Holding Corp., analysts believe AMN Healthcare Services, Inc. is more attractive than InnovAge Holding Corp..

InnovAge Holding Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AMN Healthcare Services, Inc. has a beta of 0.213, suggesting its less volatile than the S&P 500 by 78.742%.

InnovAge Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InnovAge Holding Corp. pays -- of its earnings as a dividend. AMN Healthcare Services, Inc. pays out -- of its earnings as a dividend.

InnovAge Holding Corp. quarterly revenues are $236.1M, which are smaller than AMN Healthcare Services, Inc. quarterly revenues of $634.5M. InnovAge Holding Corp.'s net income of $7.7M is lower than AMN Healthcare Services, Inc.'s net income of $29.3M. Notably, InnovAge Holding Corp.'s price-to-earnings ratio is -- while AMN Healthcare Services, Inc.'s PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding Corp. is 0.79x versus 0.23x for AMN Healthcare Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National HealthCare Corp. has a net margin of 3.25% compared to InnovAge Holding Corp.'s net margin of 10.77%. InnovAge Holding Corp.'s return on equity of -7.99% beat National HealthCare Corp.'s return on equity of 10.22%.

InnovAge Holding Corp. has a consensus price target of $5.00, signalling downside risk potential of -2.91%. On the other hand National HealthCare Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that InnovAge Holding Corp. has higher upside potential than National HealthCare Corp., analysts believe InnovAge Holding Corp. is more attractive than National HealthCare Corp..

InnovAge Holding Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National HealthCare Corp. has a beta of 0.654, suggesting its less volatile than the S&P 500 by 34.582%.

InnovAge Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National HealthCare Corp. offers a yield of 1.83% to investors and pays a quarterly dividend of $0.64 per share. InnovAge Holding Corp. pays -- of its earnings as a dividend. National HealthCare Corp. pays out 37.04% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

InnovAge Holding Corp. quarterly revenues are $236.1M, which are smaller than National HealthCare Corp. quarterly revenues of $380.8M. InnovAge Holding Corp.'s net income of $7.7M is lower than National HealthCare Corp.'s net income of $41M. Notably, InnovAge Holding Corp.'s price-to-earnings ratio is -- while National HealthCare Corp.'s PE ratio is 21.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding Corp. is 0.79x versus 1.43x for National HealthCare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sonida Senior Living, Inc. has a net margin of 3.25% compared to InnovAge Holding Corp.'s net margin of -27.9%. InnovAge Holding Corp.'s return on equity of -7.99% beat Sonida Senior Living, Inc.'s return on equity of -41.74%.

InnovAge Holding Corp. has a consensus price target of $5.00, signalling downside risk potential of -2.91%. On the other hand Sonida Senior Living, Inc. has an analysts' consensus of $28.00 which suggests that it could fall by -7.59%. Given that Sonida Senior Living, Inc. has more downside risk than InnovAge Holding Corp., analysts believe InnovAge Holding Corp. is more attractive than Sonida Senior Living, Inc..

InnovAge Holding Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonida Senior Living, Inc. has a beta of 0.591, suggesting its less volatile than the S&P 500 by 40.883%.

InnovAge Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonida Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InnovAge Holding Corp. pays -- of its earnings as a dividend. Sonida Senior Living, Inc. pays out 85.92% of its earnings as a dividend. Sonida Senior Living, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

InnovAge Holding Corp. quarterly revenues are $236.1M, which are larger than Sonida Senior Living, Inc. quarterly revenues of $98M. InnovAge Holding Corp.'s net income of $7.7M is higher than Sonida Senior Living, Inc.'s net income of -$27.3M. Notably, InnovAge Holding Corp.'s price-to-earnings ratio is -- while Sonida Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding Corp. is 0.79x versus 1.48x for Sonida Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

GeneDx Holdings Corp. has a net margin of 3.25% compared to InnovAge Holding Corp.'s net margin of -6.54%. InnovAge Holding Corp.'s return on equity of -7.99% beat GeneDx Holdings Corp.'s return on equity of 0.82%.

InnovAge Holding Corp. has a consensus price target of $5.00, signalling downside risk potential of -2.91%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $160.89 which suggests that it could fall by -0.66%. Given that InnovAge Holding Corp. has more downside risk than GeneDx Holdings Corp., analysts believe GeneDx Holdings Corp. is more attractive than InnovAge Holding Corp..

InnovAge Holding Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.025, suggesting its more volatile than the S&P 500 by 102.538%.

InnovAge Holding Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InnovAge Holding Corp. pays -- of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend.

InnovAge Holding Corp. quarterly revenues are $236.1M, which are larger than GeneDx Holdings Corp. quarterly revenues of $116.7M. InnovAge Holding Corp.'s net income of $7.7M is higher than GeneDx Holdings Corp.'s net income of -$7.6M. Notably, InnovAge Holding Corp.'s price-to-earnings ratio is -- while GeneDx Holdings Corp.'s PE ratio is 2,685.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding Corp. is 0.79x versus 11.55x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.